Skip to main content

Daily Digest: Arm's IPO expected to be largest in years; AI drug biotech scores $200M

Meanwhile, Genesis Therapeutics, a Burlingame-based AI drug discovery company, raised $200 million in funding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.